Guardant Health Appoints High-Tech-Veteran Kumud Kalia Chief Information Officer
REDWOOD CITY, Calif.,
“I’m thrilled to join a company with such a strong mission — conquering cancer with data,” said Kumud Kalia. “Guardant is poised to transform cancer care, and I am eager to lead the efforts needed to scale up Guardant’s data infrastructure to serve the tens of millions of patients around the world, and across the cancer care continuum.”
Kumud has held technology, operations, and strategy leadership roles within high-tech, energy, telecommunications, and financial services companies. He was most recently Chief Information and Technology Officer at
About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 and GuardantOMNI tests for advanced stage cancer patients and LUNAR assay for research use and for use in prospective clinical trials. In parallel, Guardant Health is actively exploring the performance of the LUNAR assay in initial studies related to screening and early detection in asymptomatic individuals.
This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the scale-up of Guardant Health’s data infrastructure, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. Such risks and uncertainties include those discussed under the caption “Risk Factors” in Guardant Health’s Annual Report on Form 10-K for the year ended December 31, 2018, and in its other reports filed by Guardant Health with the Securities and Exchange Commission. These forward-looking statements are based on current expectations, forecasts, assumptions and information available to
Lynn Lewis or Carrie Mendivil
Anna Czene or Ian Stone
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6a3dd16c-15d0-4689-86e5-cd694706d469
Source: Guardant Health, Inc.